News
BioSpace, News, Syndication »
BioSpace, News, Syndication »
BioSpace, News, Syndication »
News, Syndication, Xconomy »
[[Click headline to continue reading.]]
News, Syndication, Xconomy »
[[Click headline to continue reading.]]
BioSpace, News, Syndication »
BioSpace, News, Syndication »
SAN DIEGO, March 16 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. today announced that the underwriter of its recently completed public offering of common stock has exercised in full its option to purchase an additional 1,365,000 shares of common stock to cover over-allotments. The sale of the additional shares closed on March 16, 2010. When taking into account the sale of the... More...
BioSpace, News, Syndication »
SAN DIEGO, March 16 /PRNewswire-FirstCall/ -- Cardium Therapeutics today reported highlights and financial results for its fourth quarter and fiscal year ended December 31, 2009, and other important recent developments and outlook for 2010.
(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)
Highlights of 2009 and Recent Developments
BioSpace, News, Syndication »
BioSpace, News, Syndication »
SAN DIEGO, March 17 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy... More...
